Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

BACKGROUND: Randomized phase III trials are ongoing to investigate the efficacy of nivolumab in malignant pleural mesothelioma (MPM), but real-world data are still scarce. In this real-world study, we investigated the clinical outcomes of nivolumab treatment in pre-treated MPM patients. METHODS: Dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Luca, Belderbos, Robert A., Gooijer, Cornedine J., Dumoulin, Daphne W., Cornelissen, Robin, Baart, Sara, Burgers, Jacobus A., Baas, Paul, Aerts, Joachim G. J. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481613/
https://www.ncbi.nlm.nih.gov/pubmed/32953495
http://dx.doi.org/10.21037/tlcr-19-686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481613/
https://www.ncbi.nlm.nih.gov/pubmed/32953495
http://dx.doi.org/10.21037/tlcr-19-686

Ejemplares similares